Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kugathasan, L.
Right arrow Articles by Stewart, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kugathasan, L.
Right arrow Articles by Stewart, D. J.
(Chest. 2005;128:633S-642S.)
© 2005 American College of Chest Physicians

Role of Angiopoietin-1 in Experimental and Human Pulmonary Arterial Hypertension*

Lakshmi Kugathasan, MSc; André E. Dutly, MD; Yidan D. Zhao, MD; Yupu Deng, MD; Malcolm J. Robb, MD; Shaf Keshavjee, FCCP and Duncan J. Stewart, MD

* From the Terrence Donnelly Heart Centre (Mr. Kugathasan and Drs. Zhao, Deng, Robb, and Stewart), Division of Cardiology, St. Michael’s Hospital, Toronto, ON, Canada; and the Division of Thoracic Surgery (Drs. Dutly and Keshavjee), Toronto General Hospital, Toronto, ON, Canada.

Correspondence to: Duncan J. Stewart, Dexter Hung-Cho Man Chair and Director of the Division of Cardiology, St. Michael’s Hospital, 30 Bond St, Room 6–050K, Queen Wing, Toronto, ON, Canada, M5B 1W8; e-mail: stewartd{at}smh.toronto.on.ca

Introduction: The pulmonary microvasculature, consisting mainly of an endothelial cell (EC) monolayer and scant matrix support, is incompletely muscularized. Thus, the distal pulmonary arterioles may be predisposed to regression on exposure to environmental stresses (ie, hypoxia) and may be dependent on EC survival factors, like angiopoietin (Ang) 1, to attenuate the development of pulmonary arterial hypertension (PAH). In order to clarify the link between Ang1 expression and the development of PAH in patients, we also studied messenger RNA and protein expression in lung samples from healthy control subjects and patients with idiopathic PAH (IPAH) or PAH associated with other diseases (APAH).

Methods: Ang/Tie2 gene expression was assessed in rats that had been exposed to hypoxia (ie, 10% O2) for 1, 3, or 7 days. In a separate experiment, the cell-based gene transfer of Ang1/Ang2 was performed, and the effects were evaluated in rats with hypoxia-induced PAH.

Results: Hypoxia induced significant early increases in right ventricular systolic pressure (RVSP) and right ventricle/left ventricle-plus-septum mass ratio (RV/[LV + S]), with a significant decrease in Tie2 expression. Hypoxic rats receiving Ang1 demonstrated significant improvements in RVSP and RV/(LV + S), with a partial normalization in Tie2 protein levels. Robust Ang1 expression was observed in healthy human lungs. Furthermore, there were no significant changes in the levels of Ang1 or Ang2 in IPAH or APAH samples vs those in control subjects.

Conclusions: Decreased activity of the Tie2 pathway with hypoxia may contribute to PAH, possibly by loss of EC survival signaling, which can be overcome by Ang1 gene transfer.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.